Sage Therapeutics
SAGE
Reported
Tuesday, October 29
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.53 | -1.53 | 0.00 | 0.00% |
| Revenue | 10.8M | 11.9M | 1.07M | 9.92% |
WhatIF - Earnings
EPS Met Expectations
Sage Therapeutics (SAGE:NASDAQ) has never met expectations before
There’s a first time for everything